Assessment of Prescription Pattern of Chemotherapy in Subjects with Esophageal Cancer

Chandrani Das; Vaishnavi Prasanna; Suchitra; Joshy George Zachariah

doi:10.36948/ijfmr.2023.v05i06.10581

Assessment of Prescription Pattern of Chemotherapy in Subjects with Esophageal Cancer

Author(s)	Chandrani Das, Vaishnavi Prasanna, Suchitra, Joshy George Zachariah
Country	India
Abstract	Esophageal cancer is a disease that arises when the tissues of the esophagus generate malignant cells. In terms of its prevalence, it ranks 13th among cancers in women and 7th among cancers in men. The goal of the study is to assess prescription pattern in subjects receiving chemotherapy for esophageal cancer and this research will provide guidance to healthcare professionals on ways to utilize medications effectively and improve subjects' quality of life and survival chances while reducing potentially dangerous side effects. This was a prospective observational study carried out in the Department of Oncology in ESI MC & PGIMSR, Rajajinagar, Bengaluru. A total of 35 samples were collected, of which 28 were selected for the study. Subjects for the study were identified by the investigator during ward rounds based on the inclusion and exclusion criteria. Relevant data collected were recorded on the Self-designed data collection form. All recorded data were entered using Microsoft excel software for determining the statistical significance. The results were expressed in descriptive statistics such as percentages were calculated for categorical variables. 71% (n=20) of the subjects involved in the study were prescribed with Carboplatin. Carboplatin with paclitaxel was the most preferred combination therapy. In the present study, we have concluded that the oncologists in this hospital prefer Cytotoxic drugs over Targeted drugs for the treatment of esophageal cancer. During the covid pandemic, subject previously diagnosed with EC discontinued their therapy and follow-ups due to restrictions imposed by the government and inability to travel during lockdowns. Hence, resulted in inadequate therapy which leads to spread of cancer among the subjects and there by the therapy is changed from dual therapy (carboplatin and paclitaxel) the triple therapy.
Keywords	Esophageal cancer, Chemotherapy and Prescribing pattern
Field	Medical / Pharmacy
Published In	Volume 5, Issue 6, November-December 2023
Published On	2023-12-19
Cite This	Assessment of Prescription Pattern of Chemotherapy in Subjects with Esophageal Cancer - Chandrani Das, Vaishnavi Prasanna, Suchitra, Joshy George Zachariah - IJFMR Volume 5, Issue 6, November-December 2023. DOI 10.36948/ijfmr.2023.v05i06.10581
DOI	https://doi.org/10.36948/ijfmr.2023.v05i06.10581
Short DOI	https://doi.org/gs9k26

View / Download PDF File

E-ISSN 2582-2160

doi

CrossRef DOI is assigned to each research paper published in our journal.

IJFMR DOI prefix is
10.36948/ijfmr

Downloads

Research Paper Format Copyright Permission Form and Undertaking Form Cover Page Vol 6 Isu 3 Cover Page Vol 6 Isu 2 Cover Page Vol 6 Isu 1

All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.

CC-BY-SA

About IJFMR Fees & Payment Current Issue Publication Archive	Submit Research Paper Track Submission Status Publication Guidelines Publication Ethics Peer Review & Plagiarism	Join as a Reviewer Editors & Reviewers Reviewer Referral Program Get Reviewer Membership Certi.	Website/Journal Policies Usage Policy Content Policies Privacy Policy

Contact Us		+91-9898-5948-55	editor@ijfmr.com

International Journal For Multidisciplinary Research

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Assessment of Prescription Pattern of Chemotherapy in Subjects with Esophageal Cancer

Share this